Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intermittent Fasting Strategies on Cardiometabolic Risk: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

NCT05309057 is registered in ClinicalTrials.gov with University of Toronto as lead sponsor.

NCT NCT05309057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05309057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intermittent Fasting Strategies on Cardiometabolic Risk: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Lead sponsor
University of Toronto
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2020
Completion date
August 31, 2022
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiometabolic syndrome, cardiovascular diseases, diabetes, dyslipidemias, gout, hypertension, inflammation, metabolic syndrome, nafld, obesity, prediabetes